Related Experiment Videos
Improvement of coronary vasodilatation capacity through single LDL apheresis
K P Mellwig1, D Baller, U Gleichmann
1Clinic of Cardiology, Heart and Diabetes Center Northrhine-Westphalia, University Hospital of the Ruhr University of Bochum, Bad Oeynhausen, Germany.
Insights
Rapid LDL apheresis significantly improves coronary vasodilation in hypercholesterolemia patients. This study shows enhanced blood flow and coronary reserve within 24 hours, challenging previous assumptions about recovery timelines.
Area of Science:
- Cardiology
- Vascular Biology
- Medical Imaging
Background:
- Hypercholesterolemia impairs endothelial function, reducing coronary vasodilatation capacity.
- Conventional cholesterol-lowering therapies require weeks to months to normalize endothelial function.
- The speed of endothelial function recovery after cholesterol reduction is not well understood.
Purpose of the Study:
- To investigate the rapid effects of LDL apheresis (LDL-A) on coronary vasodilatation capacity.
- To quantitatively assess changes in coronary blood flow and reserve post-LDL-A using Positron Emission Tomography (PET).
Main Methods:
- Nine patients with coronary artery disease and hypercholesterolemia underwent PET scans before and 18-20 hours after LDL-A.
- LDL cholesterol levels, myocardial blood flow (MBF), coronary flow reserve (CFR), and minimum coronary resistance (MCR) were measured.
- Pharmacologic stress (dipyridamole) was used to recruit coronary flow capacity.
Main Results:
- LDL apheresis rapidly reduced LDL cholesterol by over 50% (194 to 81 mg/dl).
- Significant improvements were observed within 24 hours: MBF increased from 173 to 226 ml/min/100g, CFR rose from 1.91 to 2.48, and MCR decreased from 0.61 to 0.43.
- A ~30% improvement in coronary vasodilatation capacity was demonstrated non-invasively via PET.
Conclusions:
- LDL apheresis can rapidly restore coronary vasodilatation capacity within 24 hours.
- This rapid improvement challenges the presumed weeks-to-months timeline for endothelial function recovery.
- PET imaging provides a valuable tool for non-invasive, quantitative assessment of these rapid vascular changes.
Abstract:
A concomitant phenomenon of hypercholesterolemia is reduced coronary vasodilatation capacity due to disturbed endothelial function. Endothelial function can be partially or completely normalized by reducing cholesterol levels through drug therapy, but it is still unclear how rapidly this desired effect is achieved. An interval of between weeks and months has been presumed. LDL apheresis (LDL-A) is capable of achieving a high-degree LDL cholesterol reduction within hours. With positron emission tomography (PET), carried out immediately before and after LDL-A, changes in coronary reserve due to this abrupt LDL cholesterol reduction could be measured both quantitatively and non-invasively. In nine patients (six women, three men) with documented coronary artery disease and hypercholesterolemia, PET was carried out immediately before and 18-20 h after LDL-A. A reduction in LDL cholesterol (from 194 +/- 38 to 81 +/- 20 mg/dl), facilitated significant improvement in myocardial blood flow (MBF) (173 +/- 63 versus 226 +/- 79 ml/min per 100 g) after pharmacologic recruitment of coronary flow capacity (dipyridamole stress), coronary flow reserve (CFR) (1.91 +/- 0.68 versus 2.48 +/- 0.68) and minimum coronary resistance (MCR) (0.61 +/- 0.18 versus 0.43 +/- 0.16 mmHg/100 g per min per ml) within 24 h. Plasma viscosity was reduced slightly, by 6.6%. Probably for the first time, a 30% improvement in coronary vasodilatation capacity could be demonstrated quantitatively and non-invasively by PET after a single LDL-A within 24 h.